21ur-11897

Caenorhabditis elegans

Is affected by rnp-6 based on RNA-seq studies. Is affected by D-glucose based on RNA-seq studies.

seu-3

Caenorhabditis elegans

Acts upstream of or within dorsal/ventral axon guidance.

seu-2

Caenorhabditis elegans

Acts upstream of or within dorsal/ventral axon guidance.

21ur-4710

Caenorhabditis elegans

Is affected by spt-16 and rnp-6 based on RNA-seq studies. Is affected by D-glucose based on RNA-seq studies.

21ur-4206

Caenorhabditis elegans

Is affected by spt-16 and rnp-6 based on RNA-seq studies. Is affected by D-glucose based on RNA-seq studies.

21ur-7217

Caenorhabditis elegans

Is affected by several genes including hsf-1; rnp-6; and emr-1 based on RNA-seq studies. Is affected by D-glucose based on RNA-seq studies.

21ur-13425

Caenorhabditis elegans

Is affected by several genes including cpl-1; rnp-6; and hmg-3 based on RNA-seq studies. Is affected by D-glucose based on RNA-seq studies.

unc-6

Caenorhabditis elegans

Predicted to enable signaling receptor binding activity. Involved in several processes, including axon guidance; regulation of locomotion; and sex differentiation. Acts upstream of or within dendrite morphogenesis. Located in axon; basement membrane; and cytoplasm. Expressed in several structures, including P1; VA12; accessory cell; interneuron; and somatic neurons. Human ortholog(s) of this gene implicated in congenital mirror movement disorder. Is an ortholog of human NTN1 (netrin 1).

gst-6

Caenorhabditis elegans

Predicted to enable glutathione transferase activity. Involved in innate immune response. Is an ortholog of human HPGDS (hematopoietic prostaglandin D synthase).

ddo-2

Caenorhabditis elegans

Enables D-aspartate oxidase activity and D-glutamate oxidase activity. Involved in aspartate catabolic process. Predicted to be located in peroxisomal matrix. Expressed in body wall musculature; intestinal cell; and pharyngeal muscle cell.